Advanced Search

Journal of Traditional Chinese Medicine >

2025 , Vol. 45 >Issue 3: 610 - 617

DOI: https://doi.org/10.19852/j.cnki.jtcm.20250103.001

Systematic acupuncture explains acupuncture at Baihui (GV20) and Fengchi (GB20) targeting the inflammatory response to regulate migraine

  • Yu MIN ,
  • Meifeng ZHENG ,
  • Ju SUN ,
  • Zetong PENG ,
  • Zhixian CAO ,
  • Xiaohua HUANG
Expand
  • 1 Medical College of Acu-Moxi and Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou 510006, China
    2 Department of Rehabilitation Medicine, the Affiliated Panyu Central Hospital of Guangzhou Medical University, Guangzhou 511400, China
    3 Department of Rehabilitation Medicine, the Affiliated Panyu Central Hospital of Guangzhou Medical University, Guangzhou 511400, China

Received date: 2024-02-22

  Accepted date: 2024-08-29

  Online published: 2025-01-03

Supported by

Study on the Mechanism of Action of Dutong and Tiaoshen Acupuncture in Improving Upper Limb Motor Function After Ischemic Stroke based on Functional Near-infrared Spectroscopy Technology (Science and Technology Program of Panyu, 2022-Z04-107)

Fold

Abstract

OBJECTIVE: To take Baihui (GV20) and Fengchi (GB20) targeting inflammatory response to regulate migraine as an example to describe a new method for studying the mechanism of stimulating acupoints.
METHODS: The target information of Baihui (GV20) and Fengchi (GB20) was retrieved, and after intersection with migraine, Kyoto Encyclopedia of Genes and Genomes (KEGG), Reactome, and UniProt Keywords were used for functional enrichment. After selecting the main pathway, rats were selected and nitroglycerin was used for modeling, and the behavioral scores, inflammatory factors, heme oxygenase 1 (HMOX1), protein kinase B (AKT1), signal transducer and activator of transcription 3 (STAT3), phosphorylated extracellular signal-regulated kinase 1/2 (P-ERK1/ERK2) and other states of the rats in the acupuncture, twisting, and electroacupuncture groups were compared.
RESULTS: A total of 135 Baihui (GV20) targets and 27 Fengchi (GB20) targets were collected. A total of 73 target information were obtained after the intersection of these targets in migraine. These 73 targets have three main pathways: hypoxia-inducible factor 1 (HIF-1) signaling pathway, signaling by interleukins and inflammatory response. The main targets in the pathway were verified and found that interleukin-1 beta (IL-1β), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α) and HMOX1, AKT1, STAT3, P-ERK1/ERK2 can be regulated by Baihui (GV20) and Fengchi (GB20).
CONCLUSION: Baihui (GV20) and Fengchi (GB20) can regulate migraine by regulating inflammatory factors and HMOX1, AKT1, STAT3, P-ERK1/ERK2 and other changes in HIF-1 signaling pathway, Signaling by Interleukins and Inflammatory response pathways. Based on systems biology and network pharmacology, and with the model of "acupoint-target-disease", explore the research methods of systematic acupuncture and moxibustion. We believe this is a usable research direction for exploring the mechanism of acupuncture stimulation.

Key words： Baihui (GV20); Fengchi (GB20); inflammation; migraine disorders; acupuncture; systematic acupuncture

Cite this article

Yu MIN , Meifeng ZHENG , Ju SUN , Zetong PENG , Zhixian CAO , Xiaohua HUANG . Systematic acupuncture explains acupuncture at Baihui (GV20) and Fengchi (GB20) targeting the inflammatory response to regulate migraine[J]. Journal of Traditional Chinese Medicine, 2025 , 45(3) : 610 -617 . DOI: 10.19852/j.cnki.jtcm.20250103.001

References

1. Yu SY. Understanding headaches from macro to micro. Zhong Guo Teng Tong Yi Xue Za Zhi 2014; 20: 2-4.
2. Peters GL. Migraine overview and summary of current and emerging treatment options. Am J Manag Care 2019; 25: S23-34.
3. Burch R, Rizzoli P, Loder E. The prevalence and impact of migraine and severe headache in the united states: figures and trends from government health studies. Headache 2018; 58: 496-505.
4. Loo LS, Ailani J, Schim J, et al. Efficacy and safety of Iasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trials. J Headache Pain 2019; 20: 84.
5. Labastida-Ramírez A, Rubio-Beltrán E, Haanes KA, et al. Lasmiditan inhibits calcitonin gene-related peptide release in the rodent trigeminovascular system. Pain 2020; 161: 1092-9.
6. Rubio-Beltran E, Chan KY, Danser AJ, MaassenVanDenBrink A, Edvinsson L. Characterisation of the calcitonin gene-related peptide receptor antagonists ubrogepant and atogepant in human isolated coronary, cerebral and middle meningeal arteries. Cephalalgia 2020; 40: 357-66.
7. Yang Y, Chen M, Sun Y, Gao B, Chen Z, Wang Z. Safety and efficacy of ubrogepant for the acute treatment of episodic migraine: a Meta-analysis of randomized clinical trials. CNS Drugs 2020; 34: 463-71.
8. Xu Y, Cai J, Li W, et al. Examining the effector mechanisms of the feishu acupoint (BL13) in the treatment of pneumonia based on systematic acupuncture and moxibustion research. Evid Based Complement Alternat Med 2021; 5578104.
9. Du YH, Qin D. Acupuncture therapy. Beijing: People's Medical Publishing House, 2012: 105-60.
10. Shi N, Guo S, Su Y, et al. Improvement in the retention rate of transplanted fat in muscle by denervation. Aesthet Surg J 2018; 38: 1026-34.
11. Wang MM, Yu XH, Wei G, et al. Effects of liver-soothing and mind-regulating acupuncture on the expression of receptor activity-modified protein 1 and serotonin 1D receptors in migraine rats. Zhen Ci Yan Jiu 2018; 43: 440-4.
12. Chinese Acupuncture Association. Common acupoint names and locations of experimental animals part 2: rats. Zhen Ci Yan Jiu 2021; 46: 351-2.
13. Guo Y. Experimental acupuncture science. Beijing: China Traditional Chinese Medicine Press, 2016: 210-65.
14. Greco R, Demartini C, Francavilla M, Zanaboni AM, Tassorelli C. Antagonism of CGRP receptor: central and peripheral mechanisms and mediators in an animal model of chronic migraine. Cells 2022; 11: 3092.
15. Jiang Q, Di Q, Shan D, Xu Q. Nonylphenol inhibited HIF-1alpha regulated aerobic glycolysis and induced ROS mediated apoptosis in rat sertoli cells. Ecotoxicol Environ Saf 2022; 241: 113822.
16. Balamurugan K. HIF-1 at the crossroads of hypoxia, inflammation, and cancer. Int J Cancer 2016; 138: 1058-66.
17. Jain T, Nikolopoulou EA, Xu Q, Qu A. Hypoxia inducible factor as a therapeutic target for atherosclerosis. Pharmacol Ther 2018; 183: 22-33.
18. Cavestro C, Ferrero M, Mandrino S, Di Tavi M, Rota E. Novelty in inflammation and immunomodulation in migraine. Curr Pharm Des 2019; 25: 2919-36.
19. Edvinsson L, Haanes KA, Warfvinge K. Does inflammation have a role in migraine. Nat Rev Neurol 2019; 15: 483-90.
20. Sarady JK, Zuckerbraun BS, Bilban M, et al. Carbon monoxide protection against endotoxic shock involves reciprocal effects on iNOS in the lung and liver. FASEB J 2004; 18: 854-6.
21. Yu H, Littlewood T, Bennett M. Akt isoforms in vascular disease. Vascul Pharmacol 2015; 71: 57-64.
22. Hillmer EJ, Zhang H, Li HS, Watowich SS. STAT3 signaling in immunity. Cytokine Growth Factor Rev 2016; 31: 1-15.
23. Huang B, Lang X, Li X. The role of IL-6/JAK2/STAT3 signaling pathway in cancers. Front Oncol 2022; 12: 1023177.
24. Roux PP, Blenis J. ERK and p 38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 2004; 68: 320-44.
25. Lehnardt S, Massillon L, Follett P, et al. Activation of innate immunity in the CNS triggers neurodegeneration through a toll-like receptor 4-dependent pathway. Proc Natl Acad Sci USA 2003; 100: 8514-9.
26. Karimy JK, Reeves BC, Kahle KT. Targeting TLR4-dependent inflammation in post-hemorrhagic brain injury. Expert Opin Ther Targets 2020; 24: 525-33.
Options
Outlines

/

〈 〉